Emergent BioSolutions (EBS) Goodwill (2010 - 2023)

Emergent BioSolutions' Goodwill history runs 14 years deep, the most recent figure standing at $218.2 million for Q2 2023.

• In Q2 2023, Goodwill fell 2.98% year-over-year to $218.2 million; the TTM figure through Jun 2023 stood at $218.2 million (down 2.98% YoY), while the FY2022 annual figure was $218.2 million, down 2.98% from the prior year.
• Goodwill was $218.2 million for Q2 2023 at Emergent BioSolutions, roughly flat from $218.2 million in the prior quarter.
• In the past five years, Goodwill ranged from a high of $268.6 million in Q3 2019 to a low of $218.2 million in Q4 2022.
• Historically, Goodwill has averaged $249.5 million across 5 years, with a median of $266.4 million in 2020.
• The sharpest annual moves came in 2019 and 2021: Goodwill jumped 446.71% in 2019, then dropped 15.67% in 2021.
• A 5-year view of Goodwill shows it stood at $266.6 million in 2019, then gained by 0.04% to $266.7 million in 2020, then decreased by 15.67% to $224.9 million in 2021, then retreated by 2.98% to $218.2 million in 2022, then changed by 0.0% to $218.2 million in 2023.
• The last three Goodwill figures came in at $218.2 million (Q2 2023), $218.2 million (Q1 2023), and $218.2 million (Q4 2022), per Business Quant data.